Persistence of antibodies at 5-6 years of age for children who had received a primary series vaccination with a pentavalent whole-cell pertussis vaccine and a first booster with a pentavalent acellular pertussis vaccine: immunogenicity and tolerance of second booster with a tetravalent acellular vaccine at 5-6 years of age. [electronic resource]
Producer: 20040617Description: 1406-14 p. digitalISSN:- 0264-410X
- Antibodies, Bacterial -- analysis
- Antibody Formation -- immunology
- Child
- Child, Preschool
- Diphtheria-Tetanus-Pertussis Vaccine -- immunology
- Diphtheria-Tetanus-acellular Pertussis Vaccines -- adverse effects
- Female
- France -- epidemiology
- Humans
- Immunization, Secondary
- Immunoenzyme Techniques
- Immunologic Memory
- Infant
- Male
- Pertussis Vaccine -- adverse effects
- Poliovirus Vaccines -- adverse effects
- Vaccines, Combined -- adverse effects
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.